Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chris Boerner
Pharma
BMS turns focus to new growth drivers as legacy meds decline
The majority of Bristol Myers Squibb's $48.2 billion revenue haul in 2025 came from its collection of newer growth products.
Zoey Becker
Feb 5, 2026 11:45am
Bristol Myers CEO pledges to 'cast a broad net' in dealmaking
Jan 12, 2026 4:28pm
Cobenfy delivers OK debut year as BMS works to ease nerves
Oct 30, 2025 11:19am
BMS touts commercial execution, reckons with clinical setbacks
Jul 31, 2025 11:10am
The 10 highest-paid Big Pharma CEOs of 2024
Jun 16, 2025 3:00am
Bristol Myers CEO stays bullish on Cobenfy despite trial flop
Jun 12, 2025 12:43pm
